COX-2 and cancer: a new approach to an old problem

[1] Colon cancer prevention by NSAIDs: What is the mechanism of action? [J]. EUROPEAN JOURNAL OF SURGERY, 1998, 164 : 111 - 114

[2] Use of transgenic mice in identifying chemopreventive agents [J]. TOXICOLOGY LETTERS, 2000, 112 : 507 - 512

[3] Alshafie GA, 2000, ONCOL REP, V7, P1377

[4] PROSTAGLANDIN E(2) DOWN-REGULATES THE EXPRESSION OF HLA-DR ANTIGEN IN HUMAN COLON ADENOCARCINOMA CELL-LINES [J]. BIOCHEMISTRY, 1995, 34 (16) : 5604 - 5609

[5] Attiga FA, 2000, CANCER RES, V60, P4629

[6] Antiangiogenic tumour therapy: will it work? [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (06) : 216 - 222

[7] Cyclooxygenase-2 and its regulation in inflammation [J]. MEDIATORS OF INFLAMMATION, 1996, 5 (05) : 305 - 323

[8] Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors [J]. DRUGS OF TODAY, 1999, 35 (4-5): : 237 - 250

[9] BALCH CM, 1984, SURGERY, V95, P71

[10] Linking colorectal cancer to Wnt signaling [J]. CELL, 2000, 103 (02) : 311 - 320

[1] Colon cancer prevention by NSAIDs: What is the mechanism of action? [J]. EUROPEAN JOURNAL OF SURGERY, 1998, 164 : 111 - 114

[2] Use of transgenic mice in identifying chemopreventive agents [J]. TOXICOLOGY LETTERS, 2000, 112 : 507 - 512

[3] Alshafie GA, 2000, ONCOL REP, V7, P1377

[4] PROSTAGLANDIN E(2) DOWN-REGULATES THE EXPRESSION OF HLA-DR ANTIGEN IN HUMAN COLON ADENOCARCINOMA CELL-LINES [J]. BIOCHEMISTRY, 1995, 34 (16) : 5604 - 5609

[5] Attiga FA, 2000, CANCER RES, V60, P4629

[6] Antiangiogenic tumour therapy: will it work? [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (06) : 216 - 222

[7] Cyclooxygenase-2 and its regulation in inflammation [J]. MEDIATORS OF INFLAMMATION, 1996, 5 (05) : 305 - 323

[8] Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors [J]. DRUGS OF TODAY, 1999, 35 (4-5): : 237 - 250

[9] BALCH CM, 1984, SURGERY, V95, P71

[10] Linking colorectal cancer to Wnt signaling [J]. CELL, 2000, 103 (02) : 311 - 320